This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a benzyl group and difluoropyrrolidine moiety, makes it valuable for developing compounds with potential biological activity. It is often employed in the design and optimization of drug candidates targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases. Additionally, its incorporation into molecules can enhance their pharmacokinetic properties, including bioavailability and metabolic stability. Researchers also explore its use in creating novel inhibitors for enzymes or receptors involved in disease pathways, contributing to the development of targeted therapies.